Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 1.85B | 746.6% |
| Gross Profit | 1.06B | 745.7% |
| Cost of Revenue | 795M | 107.6% |
| Operating expense | 1.42B | 4.8% |
| Net Income | 13M | 101% |
| EBITDA | -18M | 98.6% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 15.8B | 0.8% |
| Total Liabilities | 3.88B | 2.3% |
| Total Equity | 11.9B | 1.8% |
| Shares Outstanding | 385M | 0.3% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -1.57B | 22.9% |
| Cash from investing | 721M | 56.3% |
| Cash from financing | 11M | 67.6% |
EPS
Financial Highlights for Moderna in Q3 '24
Moderna reported a revenue of 1.85B, which is a 746.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.06B, marking a 745.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 795M, a 107.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.42B, showing a -4.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 13M, showing a 101% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -18M, showing a 98.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Moderna with growth in revenue, gross profit, and net income.
